AON-mediated exon skipping has enabled the successful reframing of the mutated dystrophin mRNA and the restoration of dystrophin protein synthesis in skeletal muscle of Duchenne muscular dystrophy (DMD) patients [18], [19]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.